Task: Answer the multiple-choice question.
Question: Which compound exhibits a 6.613% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] COc1ccc(OCC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
[b] Cc1ccc(S(=O)(=O)N2CCCC(C)C2)cc1
[c] Cc1scc(C(=O)N2CCN(c3ccc(Cl)cc3)CC2)c1C
[d] Cc1cc(N2CCOCC2)nc(C(C)C)n1
[e] O=C(c1ccc(N2CCCC2)c([N+](=O)[O-])c1)N1CCc2ccccc2C1
Answer: d. Cc1cc(N2CCOCC2)nc(C(C)C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(N2CCOCC2)nc(C(C)C)n1
Cc1cc(N2CCOCC2)nc(C(C)C)n1
4-(6-methyl-2-propan-2-ylpyrimidin-4-yl)morpholine